Search research articles
Contact Us
Filters
Showing results (101-110 of 935) with videos related to
Page
of 94
Sort By:
BMJ (Clinical Research Ed.)
|
July 3, 2004
Postmarketing surveillance is needed
Venkoba R Srinivas
European Journal of Drug Metabolism and Pharmacokinetics
|
February 20, 2010
Genetic CYP2C19 polymorphism dependent non-responders to clopidogrel therapy--does structural design, dosing and induction strategies have a role to play?
Nuggehally R Srinivas
Alimentary Pharmacology & Therapeutics
|
June 8, 2017
Letter: sublingual dosing of tacrolimus in transplant patients-interesting concept to overcome first pass effects
N R Srinivas
International Journal of Clinical Pharmacology and Therapeutics
|
February 9, 2010
Is 1-methylxanthine an ideal model substrate for establishing the renal tubular transport of organic ions?
N R Srinivas
Biomedical Chromatography : BMC
|
June 9, 2017
Severe metabolic impairment with increasing age for CYP3A and CYP2D substrates in rats: Possible consequences for drug development
Nuggehally R Srinivas
Drug Research
|
April 10, 2018
Clinical Pharmacology Considerations for Development of β Lactamase Inhibitor Combination with Antibiotics
Nuggehally R Srinivas
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
March 13, 2009
Drug-drug interaction studies in preclinical species: should metabolite(s) kinetics be studied?
N R Srinivas
Drug Metabolism and Pharmacokinetics
|
May 12, 2009
Suspected differential interactions of digoxin with imidafenacin and propantheline; some thoughts for introspection
Nuggehally R Srinivas
Current Clinical Pharmacology
|
January 20, 2009
Structurally modified 'dietary flavonoids': are these viable drug candidates for chemoprevention?
Nuggehally R Srinivas
Primary Care Respiratory Journal : Journal of the General Practice Airways Group
|
January 28, 2009
Unsuspected polymorphic metabolism of rupatadine via its primary metabolite, desloratadine
Nuggehally R Srinivas
Page
of 94
Search research articles
Search
Showing results (101-110 of 935) with videos related to
Sort By:
Page
of 94
BMJ (Clinical Research Ed.)
|
July 3, 2004
Postmarketing surveillance is needed
Venkoba R Srinivas
European Journal of Drug Metabolism and Pharmacokinetics
|
February 20, 2010
Genetic CYP2C19 polymorphism dependent non-responders to clopidogrel therapy--does structural design, dosing and induction strategies have a role to play?
Nuggehally R Srinivas
Alimentary Pharmacology & Therapeutics
|
June 8, 2017
Letter: sublingual dosing of tacrolimus in transplant patients-interesting concept to overcome first pass effects
N R Srinivas
International Journal of Clinical Pharmacology and Therapeutics
|
February 9, 2010
Is 1-methylxanthine an ideal model substrate for establishing the renal tubular transport of organic ions?
N R Srinivas
Biomedical Chromatography : BMC
|
June 9, 2017
Severe metabolic impairment with increasing age for CYP3A and CYP2D substrates in rats: Possible consequences for drug development
Nuggehally R Srinivas
Drug Research
|
April 10, 2018
Clinical Pharmacology Considerations for Development of β Lactamase Inhibitor Combination with Antibiotics
Nuggehally R Srinivas
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
March 13, 2009
Drug-drug interaction studies in preclinical species: should metabolite(s) kinetics be studied?
N R Srinivas
Drug Metabolism and Pharmacokinetics
|
May 12, 2009
Suspected differential interactions of digoxin with imidafenacin and propantheline; some thoughts for introspection
Nuggehally R Srinivas
Current Clinical Pharmacology
|
January 20, 2009
Structurally modified 'dietary flavonoids': are these viable drug candidates for chemoprevention?
Nuggehally R Srinivas
Primary Care Respiratory Journal : Journal of the General Practice Airways Group
|
January 28, 2009
Unsuspected polymorphic metabolism of rupatadine via its primary metabolite, desloratadine
Nuggehally R Srinivas
Page
of 94